2026 NPPES data Hematology & Oncology Physician NPI 1962452474 M.D.
Verify on CMS →

ROBYN YOUNG, M.D.

Hematology & Oncology Physician in FORT WORTH, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 313 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
95%
generic claims · 5% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$9.0K
134 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ROBYN YOUNG, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 1,733 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
2K
Part D claims, 2023
95%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBYN YOUNG, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ROBYN YOUNG, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ROBYN YOUNG, M.D.?

Below national average

NPI registry status

Active

Issued 05/12/2006

NPI 1962452474

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

1,733 105% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Texas

How Hematology & Oncology Physician compares to other specialties among Texas providers

Texas providers

Hematology & Oncology Physician share within Texas

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Texas

Medicare quality performance — MIPS

ROBYN YOUNG, M.D.'s 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Hematology & Oncology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBYN YOUNG, M.D. appears in the CMS NPPES registry as a Hematology & Oncology Physician provider holding M.D. credentials at 800 W MAGNOLIA AVE, FORT WORTH, TX, 76104, with a listed phone of (817) 759-7000. NPI 1962452474 was issued on 05/12/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what YOUNG most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,733 prescription claims written by this provider, covering 313 Medicare beneficiaries and totaling roughly $872K in drug spend, split 5% brand-name and 95% generic by claim count, with an opioid prescribing rate of 5.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

800 W MAGNOLIA AVE
FORT WORTH, TX 76104

Provider Details

NPI 1962452474
Specialty Hematology & Oncology Physician
Credentials M.D.
Gender Female
NPI Issued 05/12/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where ROBYN YOUNG, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

ONCOLOGY HEMATOLOGY CONSULTANTS, PA
WEATHERFORD, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBYN YOUNG, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$9.0K

Largest payer

PFIZER INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to ROBYN YOUNG, M.D.. To verify ROBYN YOUNG, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ROBYN YOUNG, M.D. — brand share 5.0%
Specialty average (est.)

5% brand-name claims vs 95% generic, on 1,733 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,733
Total Claims
$872K
Total Drug Cost
313
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,944
Total Day Supply
83,312
Brand vs Generic
5% brand / 95% generic
Brand Drug Cost
$751K
Generic Drug Cost
$121K
Opioid Claims
96 (5.5% rate)
Antibiotic Claims
17

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.54
Age Distribution
<65: 21, 65-74: 168, 75-84: 108, 85+: 16

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROBYN YOUNG, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Anastrozole
570
Venlafaxine Hcl Er
Venlafaxine Hcl
165
Gabapentin
121
Letrozole
108
Duloxetine Hcl
66
Bupropion Xl
Bupropion Hcl
47
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
43
Ondansetron Odt
Ondansetron
43
Tamoxifen Citrate
33
Prochlorperazine Maleate
32

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How ROBYN YOUNG, M.D. fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

ROBYN YOUNG, M.D.'s 1,733 claims are above the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as YOUNG.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBYN YOUNG, M.D.'s specialty?
ROBYN YOUNG, M.D. specializes in Hematology & Oncology Physician and practices in FORT WORTH, Texas. Credentials: M.D..
How much does ROBYN YOUNG, M.D. prescribe under Medicare Part D?
In 2023, ROBYN YOUNG, M.D. wrote 1,733 Medicare Part D claims totaling $872K in drug costs for 313 beneficiaries.
What is ROBYN YOUNG, M.D.'s Medicare quality score?
ROBYN YOUNG, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBYN YOUNG, M.D. located?
ROBYN YOUNG, M.D. is located at 800 W MAGNOLIA AVE, FORT WORTH, TX, 76104. Phone: (817) 759-7000.
What is ROBYN YOUNG, M.D.'s NPI number?
ROBYN YOUNG, M.D.'s National Provider Identifier (NPI) is 1962452474, issued on 05/12/2006.
Does ROBYN YOUNG, M.D. prescribe more brand-name or generic drugs?
ROBYN YOUNG, M.D.'s prescribing is 5% brand-name and 95% generic drugs by claim count, with $751K in brand drug costs.
Does ROBYN YOUNG, M.D. prescribe opioids?
Yes, ROBYN YOUNG, M.D. had 96 opioid claims in 2023 with an opioid prescribing rate of 5.5%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does ROBYN YOUNG, M.D. prescribe most often?
Based on 2023 Medicare Part D data, ROBYN YOUNG, M.D.'s most frequently prescribed drugs include Anastrozole, Venlafaxine Hcl Er, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBYN YOUNG, M.D. accept Medicare?
ROBYN YOUNG, M.D. appears in CMS Medicare data with 1,733 Part D claims and 313 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBYN YOUNG, M.D.'s credentials?
ROBYN YOUNG, M.D.'s NPI is 1962452474 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology